Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

Rep. Jonathan Jackson's filing reports that a joint account purchased · $1,001 – $15,000 · Owner: Joint

Disclosures are reported transactions, not verified real-time portfolio holdings.